rockie - What I've been saying is that it appears Charles is doing everything under the sun to separate ENZC's IP/Value (BGEN & VIRO, where C3, AI, plandemic19 mABS, ITV-1, etc... all reside) from ENZC. If you noticed a few months ago, when Charles put out PR's, he started putting them out under BGEN/VIRO instead of under ENZC, how they've always been done. He would put the PR under ENZC, then talk abut the IP/subs in that PR, but it was all associated as ENZC. A few months ago, that changed, and all PR's began coming out under BGEN or VIRO.
If I had to guess, I'd say that he's doing it to separate the value from the lawsuits, but that's just a guess. My frustration comes from the fact that for 2.5-3 years he/Chandra led us all to believe that everything was going to happen under ENZC.
1. Conservative estimate of C3 earnings = $9.09B per year
2. Audit Completed
3. SEC Reporting
4. Institutional Investors & BP partners join the party
5. Uplist
Now the IP/Value that we've all been holding and waiting for it's full value to be realized, is going to be sold to a bottom of the barrel of SPAC (Can't even complete a 10Q or update as to why they can't complete it, but I guess that fits well with a company/CEO who hasn't been able to file a single Q or K on time without an extension) for a whopping $450M (Really just shares valued at $10-11). It seems to me that either bait & switch was pulled or something happened that forced Charles to do a complete 180 on everything we were led to believe for the past 2.5-3 years.
Anyway, we don't know what we don't know, but I'd really love to know what happened to Samsung? What happened to ENZO after he was given C3? Where is the audit? Where is SEC Reporting?
At this point, it is what it is, and like I've been saying, I'm just holding on and hoping for some kind of miracle and/or surprise. However, the fact that we're almost 11 months into 2023, still in pinks, still unaudited and alternative reporting, and sitting at a MC under $100M is sad and worrisome.
